{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:03:10Z","timestamp":1790647390774,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T00:00:00Z","timestamp":1448409600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s13277-015-4471-2","type":"journal-article","created":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T22:42:23Z","timestamp":1448491343000},"page":"6085-6090","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Wnt5a and Ror2 expression associate with the disease progress of primary thyroid lymphoma"],"prefix":"10.1007","volume":"37","author":[{"given":"Lei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Hou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Ming","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Yuan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Jie","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,25]]},"reference":[{"key":"4471_CR1","first-page":"316","volume":"26","author":"SM Ansell","year":"1999","unstructured":"Ansell SM, Grant CS, Habermann TM. Primary thyroid lymphoma. Semin Oncol. 1999;26:316\u201323.","journal-title":"Semin Oncol"},{"issue":"1","key":"4471_CR2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1365-2559.1996.268311.x","volume":"28","author":"RK Pedersen","year":"1996","unstructured":"Pedersen RK, Pedersen NT. Primary non-Hodgkin\u2019s lymphoma of the thyroid gland: a population based study. Histopathology. 1996;28(1):25\u201332.","journal-title":"Histopathology"},{"issue":"3","key":"4471_CR3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1507\/endocrj.K08E-355","volume":"56","author":"YC Hwang","year":"2009","unstructured":"Hwang YC, Kim TY, Kim WB, et al. Clinical characteristics of primary thyroid lymphoma in Koreans. Endocr J. 2009;56(3):399\u2013405.","journal-title":"Endocr J"},{"issue":"6","key":"4471_CR4","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.surg.2009.09.020","volume":"146","author":"A Graff-Baker","year":"2009","unstructured":"Graff-Baker A, Roman SA, Thomas DC. Prognosis of primary thyroid lymphoma: demographic, clinical and pathologic predictors of survival in 1408 cases. Surgery. 2009;146(6):1105\u201315.","journal-title":"Surgery"},{"key":"4471_CR5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11864-004-0021-7","volume":"5","author":"S Widder","year":"2004","unstructured":"Widder S, Pasieka JL. Primary thyroid lymphomas. Curr Treat Options Oncol. 2004;5:307\u201313.","journal-title":"Curr Treat Options Oncol"},{"key":"4471_CR6","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1089\/thy.1999.9.1273","volume":"9","author":"P Kossev","year":"1999","unstructured":"Kossev P, Livolsi V. Lymphoid lesions of the thyroid: review in light of the revised European American lymphoma classification and upcoming World Health Organization classification. Thyroid. 1999;9:1273\u201380.","journal-title":"Thyroid"},{"issue":"2","key":"4471_CR7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/hed.22928","volume":"35","author":"R Katna","year":"2013","unstructured":"Katna R, Shet T, Sengar M. Clinicopathologic study and outcome analysis of thyroid lymphomas: experience from a tertiary cancer center. Head Neck. 2013;35(2):165\u201371.","journal-title":"Head Neck"},{"issue":"4","key":"4471_CR8","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1016\/j.suronc.2010.06.002","volume":"19","author":"GH Sakorafas","year":"2010","unstructured":"Sakorafas GH, Kokkoris P, Farley DR. Primary thyroid lymphoma (correction of lympoma): diagnostic and therapeutic dilemmas. Surg Oncol. 2010;19(4):e124\u20139.","journal-title":"Surg Oncol"},{"issue":"4","key":"4471_CR9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3857\/roj.2013.31.4.177","volume":"31","author":"H Cha","year":"2013","unstructured":"Cha H, Kim JW, Suh CO. Patterns of care and treatment outcomes for primary thyroid lymphoma: a single institution study. Radiat Oncol J. 2013;31(4):177\u201384.","journal-title":"Radiat Oncol J"},{"key":"4471_CR10","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.otohns.2005.07.040","volume":"133","author":"FP Ruggiero","year":"2005","unstructured":"Ruggiero FP, Frauenhoffer E, Stack BC. Thyroid lymphoma: a single institution\u2019s experience. Otolaryngol Head Neck Surg. 2005;133:888\u201396.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"4471_CR11","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1146\/annurev.cellbio.20.010403.113126","volume":"20","author":"CY Logan","year":"2004","unstructured":"Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 2004;20:781\u2013810.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"18","key":"4471_CR12","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1016\/j.febslet.2010.08.030","volume":"584","author":"F Verkaar","year":"2010","unstructured":"Verkaar F, Zaman GJ. A model for signaling specificity of Wnt\/Frizzled combinations through co-receptor recruitment. FEBS Lett. 2010;584(18):3850\u20134.","journal-title":"FEBS Lett"},{"key":"4471_CR13","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1073\/pnas.0509703103","volume":"103","author":"T Pukrop","year":"2006","unstructured":"Pukrop T, Klemm F, Hagemann T, et al. Wnt5a signaling is critical for macrophage-induced invasion of breast cancer cell lines. Proc Natl Acad Sci U S A. 2006;103:5454\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4471_CR14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/onc.2009.305","volume":"29","author":"MP O\u2019Connell","year":"2010","unstructured":"O\u2019Connell MP, Fiori JL, Xu M, et al. The orphan tyrosine kinase receptor, Ror2, mediates Wnt5A signaling in metastatic melanoma. Oncogene. 2010;29:34\u201344.","journal-title":"Oncogene"},{"key":"4471_CR15","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/carcin\/bgl255","volume":"28","author":"S Ripka","year":"2007","unstructured":"Ripka S, Konig A, Buchholz M, et al. WNT5A\u2014target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer. Carcinogenesis. 2007;28:1178\u201387.","journal-title":"Carcinogenesis"},{"issue":"1","key":"4471_CR16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1053\/j.gastro.2009.02.003","volume":"137","author":"H Yamamoto","year":"2009","unstructured":"Yamamoto H, Kitadai Y, Yamamoto H, et al. Laminin gamma2 mediates Wnt5a-induced invasion of gastric cancer cells. Gastroenterology. 2009;137(1):242\u201352. 252.e1-6.","journal-title":"Gastroenterology"},{"issue":"36","key":"4471_CR17","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1038\/onc.2009.175","volume":"28","author":"M Enomoto","year":"2009","unstructured":"Enomoto M, Hayakawa S, Itsukushima S, et al. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a\/Ror2 signaling. Oncogene. 2009;28(36):3197\u2013208.","journal-title":"Oncogene"},{"key":"4471_CR18","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1242\/dev.025767","volume":"135","author":"F He","year":"2008","unstructured":"He F, Xiong W, Yu X, et al. Wnt5a regulates directional cell migration and cell proliferation via Ror2-mediated noncanonical pathway in mammalian palate development. Development. 2008;135:3871\u20139.","journal-title":"Development"},{"issue":"2","key":"4471_CR19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.bjc.6605174","volume":"101","author":"SL McDonald","year":"2009","unstructured":"McDonald SL, Silver A. The opposing roles of Wnt-5a in cancer. Br J Cancer. 2009;101(2):209\u201314.","journal-title":"Br J Cancer"},{"issue":"13","key":"4471_CR20","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1038\/sj.onc.1208370","volume":"24","author":"N Kremenevskaja","year":"2005","unstructured":"Kremenevskaja N, von Wasielewski R, Rao AS, et al. Wnt-5a has tumor suppressor activity in thyroid carcinoma. Oncogene. 2005;24(13):2144\u201354.","journal-title":"Oncogene"},{"key":"4471_CR21","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10552-008-9147-4","volume":"19","author":"X Han","year":"2008","unstructured":"Han X, Kilfoy B, Zheng T, et al. Lymphoma survival patterns by WHO subtype in the United States, 1973\u20132003. Cancer Causes Control. 2008;19:841\u201358.","journal-title":"Cancer Causes Control"},{"issue":"1","key":"4471_CR22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1210\/jcem.87.1.8156","volume":"87","author":"C Thieblemont","year":"2002","unstructured":"Thieblemont C, Mayer A, Dumontet C, et al. Primary thyroid lymphoma is a heterogeneous disease. J Clin Endocrinol Metab. 2002;87(1):105\u201311.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4471_CR23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.gde.2009.11.004","volume":"20","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Karin M. Inflammation and oncogenesis: a vicious connection. Curr Opin Genet Dev. 2010;20(1):65\u201371.","journal-title":"Curr Opin Genet Dev"},{"issue":"4","key":"4471_CR24","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1371\/journal.pbio.0040115","volume":"4","author":"AJ Mikels","year":"2006","unstructured":"Mikels AJ, Nusse R. Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol. 2006;4(4):e115.","journal-title":"PLoS Biol"},{"issue":"1","key":"4471_CR25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4049\/jimmunol.1102297","volume":"188","author":"J Kim","year":"2012","unstructured":"Kim J, Kim DW, Chang W, et al. Wnt5a is secreted by follicular dendritic cells to protect germinal center B cells via Wnt\/Ca2+\/NFAT\/NF-\u03baB-B cell lymphoma 6 signaling. J Immunol. 2012;188(1):182\u20139.","journal-title":"J Immunol"},{"issue":"2","key":"4471_CR26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.molcel.2009.12.022","volume":"37","author":"JM Lee","year":"2010","unstructured":"Lee JM, Kim IS, Kim H, et al. RORalpha attenuates Wnt\/beta-catenin signaling by PKCalpha-dependent phosphorylation in colon cancer. Mol Cell. 2010;37(2):183\u201395.","journal-title":"Mol Cell"},{"issue":"5","key":"4471_CR27","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1083\/jcb.200303158","volume":"162","author":"L Topol","year":"2003","unstructured":"Topol L, Jiang X, Choi H, et al. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent \u03b2-catenin degradation. J Cell Biol. 2003;162(5):899\u2013908.","journal-title":"J Cell Biol"},{"issue":"1","key":"4471_CR28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/emboj.2009.322","volume":"29","author":"A Sato","year":"2010","unstructured":"Sato A, Yamamoto H, Sakane H, et al. Wnt5a regulates distinct signalling pathways by binding to Frizzled2. EMBO J. 2010;29(1):41\u201354.","journal-title":"EMBO J"},{"issue":"7","key":"4471_CR29","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/sj.onc.1208255","volume":"24","author":"E Blanc","year":"2005","unstructured":"Blanc E, Roux GL, B\u00e9nard J, et al. Low expression of Wnt-5a gene is associated with high-risk neuroblastoma. Oncogene. 2005;24(7):1277\u201383.","journal-title":"Oncogene"},{"issue":"2A","key":"4471_CR30","first-page":"731","volume":"25","author":"AC Leris","year":"2005","unstructured":"Leris AC, Roberts TR, Jiang WG, et al. WNT5A expression in human breast cancer. Anticancer Res. 2005;25(2A):731\u20134.","journal-title":"Anticancer Res"},{"issue":"3","key":"4471_CR31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1535-6108(02)00045-4","volume":"1","author":"AT Weeraratna","year":"2002","unstructured":"Weeraratna AT, Jiang Y, Hostetter G, et al. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell. 2002;1(3):279\u201388.","journal-title":"Cancer Cell"},{"issue":"18","key":"4471_CR32","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.1158\/1078-0432.CCR-07-5104","volume":"14","author":"PD Forno Da","year":"2008","unstructured":"Da Forno PD, Pringle JH, Hutchinson P, et al. WNT5A expression increases during melanoma progression and correlates with outcome. Clin Cancer Res. 2008;14(18):5825\u201332.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"4471_CR33","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1535-6108(03)00268-X","volume":"4","author":"H Liang","year":"2003","unstructured":"Liang H, Chen Q, Coles AH, et al. Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. Cancer Cell. 2003;4(5):349\u201360.","journal-title":"Cancer Cell"},{"issue":"4","key":"4471_CR34","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1083\/jcb.200607127","volume":"175","author":"M Nishita","year":"2006","unstructured":"Nishita M, Yoo SK, Nomachi A, et al. Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for Wnt5a-induced cell migration. J Cell Biol. 2006;175(4):555\u201362.","journal-title":"J Cell Biol"},{"issue":"1","key":"4471_CR35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.devcel.2008.05.007","volume":"15","author":"S Yamamoto","year":"2008","unstructured":"Yamamoto S, Nishimura O, Misaki K, et al. Cthrc1 selectively activates the planar cell polarity pathway of Wnt signaling by stabilizing the Wnt-receptor complex. Dev Cell. 2008;15(1):23\u201336.","journal-title":"Dev Cell"},{"issue":"22","key":"4471_CR36","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1101\/gad.1957710","volume":"24","author":"L Grumolato","year":"2010","unstructured":"Grumolato L, Liu G, Mong P, et al. Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors. Genes Dev. 2010;24(22):2517\u201330.","journal-title":"Genes Dev"},{"issue":"27","key":"4471_CR37","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1038\/onc.2009.116","volume":"28","author":"TM Wright","year":"2009","unstructured":"Wright TM, Brannon AR, Gordan JD, et al. Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma. Oncogene. 2009;28(27):2513\u201323.","journal-title":"Oncogene"},{"issue":"11","key":"4471_CR38","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S0962-8924(01)02122-5","volume":"11","author":"C Chang","year":"2001","unstructured":"Chang C, Werb Z. The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol. 2001;11(11):S37\u201343.","journal-title":"Trends Cell Biol"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4471-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-4471-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4471-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4471-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T19:06:54Z","timestamp":1553627214000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-4471-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,25]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["4471"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-4471-2","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,25]]}}}